1,9811,645Commitments and contingenciesStockholders' equityPreferred stock, $.01 par value - authorized 50,000,000shares, none issued and outstandingCommon stock, $.01 par value - authorized 2,000,000,000shares and issued 1,531,013,482 shares as of September 30, 2011

1515and 1,520,780,112 shares as of December 31, 2010Treasury stock, at cost - 30,000,000 shares as of September 30, 2011

(192)Additional paid-in capital

16,31816,232Accumulated deficit

(4,488)(4,822)Accumulated other comprehensive loss, net of tax

(132)(129)Total stockholders' equity

11,52111,296$
21,502$
22,128BOSTON SCIENTIFIC CORPORATIONNON-GAAP NET INCOME AND NET INCOME PER COMMON SHARE RECONCILIATIONS

(Unaudited)Three Months Ended September 30,20112010ImpactImpactNetper dilutedNetper dilutedin millions, except per share data

incomeshareincomeshareGAAP net income$   142$
.09$
90$
.12Non-GAAP adjustments:Intangible asset impairment charges